Resultados de la búsqueda 1131-1140 of 6272 for decrease application based
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
... application of potential biomarkers of risk to this archival tissue set; and, the discovery of new, potentially relevant biomarkers of risk in fresh and ...
... decline (e.g., Mueller et al, 2018). We propose to add a series of in-clinic ... Android App on Google Play · Apple Download on the App Store · Términos y ...
Rochester, Minn. The purpose of this study is to determine whether transverse/sigmoid sinus junction stenting reduces the risk of recurrent cerebrospinal fluid ...
The purpose of this study is to evaluate clinical complications, pattern of kidney function decline and identification of clinical variables related to ...
Subsequent therapy will be based upon MIBG avidity and ALK status. Patients ... Android App on Google Play · Apple Download on the App Store · Términos y ...
... decrease inflammatory cytokines (11) and decrease ... Recently, the EDII was developed and validated to assess inflammatory potential of diet based on the Food ...
... reducing the rate of of all-cause medically ... Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay ...
The postnatal diagnosis of Long QT Syndrome (LQTS) is suggested by a prolonged QT interval on 12 lead electrocardiogram (ECG),a positive family history ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?